Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Filings indexed 449 across all filing types
Latest filing 2025-03-25 Call Transcript
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
关于投资者关系活动记录表的公告
Call Transcript Classification · 95% confidence The document is an investor relations activity record from 湖北一致魔芋生物科技股份有限公司 dated March 26, 2025. It details a Q&A session from an investor conference call or meeting, discussing production capacity, cooperation with clients, raw material prices, and social responsibility. The content is focused on investor communication and company updates but does not contain formal financial statements or comprehensive financial data. The document length is 2315 characters, which is relatively short and more consistent with a meeting or call transcript rather than a full financial report. Therefore, the document fits best as a Call Transcript (CT) rather than an Annual Report, Interim Report, or Earnings Release.
2025-03-25 Chinese
关于召开2024年年度股东大会通知公告(提供网络投票)
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of 湖北一致魔芋生物科技股份有限公司. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed at the AGM such as the 2024 board work report, supervisory board report, independent directors' reports, financial reports, budget reports, annual report, special reports on fund usage, internal control evaluation, dividend distribution plan, audit firm reappointment, and remuneration plans for 2025. The document also provides instructions for shareholder registration and attendance, contact information, and references to related documents disclosed on the stock exchange information platform. The content is consistent with materials typically shared to inform shareholders about the AGM and facilitate their participation and voting. It is not the annual report itself, nor a financial report, but rather the official announcement and notice of the AGM with agenda details and procedural information. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-03-23 Chinese
第三届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 21st meeting of the 3rd Board of Directors of 湖北一致魔芋生物科技股份有限公司. It includes multiple agenda items such as approval of strategic plans, financial reports, audit reports, remuneration plans, and proposals to be submitted to the shareholders' meeting. The document references various reports and disclosures that are separately published on the Beijing Stock Exchange information platform, indicating that this document itself is a board meeting resolution announcement rather than the reports themselves. The content focuses on board decisions and approvals rather than presenting full financial statements or detailed financial analysis. Therefore, this document fits best into the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management. The document length (7526 characters) and detailed meeting content support this classification rather than a simple announcement or a full annual report.
2025-03-23 Chinese
2024年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as an annual report summary and contains detailed financial data for the year 2024, including assets, net profit, earnings per share, and shareholder structure. It also includes management assurances about the accuracy of the report, audit opinions, dividend distribution plans, and detailed company business descriptions and operations. The length of the document (6874 characters) and the presence of substantive financial data and analysis confirm it is the actual report, not just an announcement or summary. The content matches the characteristics of an Annual Report (10-K) filing, which covers comprehensive company activity and full financial performance for the fiscal year. FY 2024
2025-03-23 Chinese
2024年度独立董事述职报告(钱和)
Board/Management Information Classification · 95% confidence The document is titled '2024 年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It is a detailed report by an independent director about their duties, attendance, opinions, committee participation, and other activities during the year 2024. The content focuses on governance, oversight, and compliance activities rather than financial results or audit opinions. It does not contain financial statements or audit results, nor is it an announcement of voting results or management changes. The document is a management-related report focusing on board and director activities, which fits best under Board/Management Information (MANG). The document length is 3473 characters, which is substantial for a report of this nature and not a brief announcement. Therefore, the classification is MANG with high confidence.
2025-03-23 Chinese
第三届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 湖北一致魔芋生物科技股份有限公司 regarding various agenda items including approval of the 2024 Supervisory Board Work Report, 2024 Financial Final Report, 2025 Financial Budget Report, 2024 Annual Report, and other related reports. It also mentions that these reports have been or will be disclosed on the Beijing Stock Exchange information platform, indicating this document itself is a meeting resolution summary rather than the full reports. The document is about the Supervisory Board meeting decisions and approvals, not the full annual report or audit report itself. It is a formal announcement of meeting resolutions, which fits best under Regulatory Filings (RNS) as it does not contain the full financial statements or detailed reports but announces the resolutions and references where the full reports can be found.
2025-03-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.